计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
M413588-5mg |
5mg |
现货 ![]() |
| |
M413588-10mg |
10mg |
现货 ![]() |
| |
M413588-25mg |
25mg |
现货 ![]() |
| |
M413588-50mg |
50mg |
现货 ![]() |
| |
M413588-100mg |
100mg |
现货 ![]() |
|
别名 | (S)-四氢呋喃-3-基 3-(3-(3-甲氧基-4-(恶唑-5-基)苯基)脲基)苄基氨基甲酸酯 | 美罗哌卡因 |
---|---|
英文别名 | PHENETHYLAMINE, beta-METHYL- | A919457 | Merimepodib [USAN:INN] | Merimebodib | 2-Naphthaleneacetic acid, 99% | carbamic acid, [[3-[[[[3-methoxy-4-(5-oxazolyl)phenyl]amino]carbonyl]amino]phenyl]methyl]-, (3S)-tetrahydro-3-furanyl ester | DTXSID70173639 | |
规格或纯度 | Moligand™, ≥98% |
英文名称 | Merimepodib |
生化机理 | 美利美泊地(Merimempodib,MMPD,VI-21,497,VX-497)是一种强效、特异性和可逆的单磷酸肌苷脱氢酶(IMPDH)抑制剂,在体外对丙型肝炎病毒(HCV)以及多种DNA和RNA病毒具有抗病毒活性。 |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
作用类型 | 抑制剂 |
作用机制 | 肌苷-5'-单磷酸脱氢酶 1 抑制剂 |
产品介绍 |
Merimepodib (VX-497) 是非竞争型,有口服活性的肌苷一磷酸脱氢酶 (IMPDH) 抑制剂,具有广谱抗病毒活性。 Information Merimepodib Merimepodib (Merimempodib, MMPD, VI-21,497, VX-497) is a potent, specific, and reversible inosine monophosphate dehydrogenase(IMPDH) inhibitor with antiviral activity against hepatitis C virus (HCV) and a variety of DNA and RNA viruses in vitro.Merimepodib is an immunosuppressive agent. Targets IMPDH |
ALogP | 1.762 |
---|---|
HBD Count | 3 |
Rotatable Bond | 8 |
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504757378 |
---|---|
分子类型 | 小分子 |
IUPAC Name | [(3S)-oxolan-3-yl] N-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate |
INCHI | InChI=1S/C23H24N4O6/c1-30-20-10-17(5-6-19(20)21-12-24-14-32-21)27-22(28)26-16-4-2-3-15(9-16)11-25-23(29)33-18-7-8-31-13-18/h2-6,9-10,12,14,18H,7-8,11,13H2,1H3,(H,25,29)(H2,26,27,28)/t18-/m0/s1 |
InChi Key | JBPUGFODGPKTDW-SFHVURJKSA-N |
Canonical SMILES | COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4 |
Isomeric SMILES | COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)O[C@H]3CCOC3)C4=CN=CO4 |
PubChem CID | 153241 |
分子量 | 452.46 |
溶解性 | Solubility (25°C) In vitro DMSO: 90 mg/mL (198.91 mM); Water: Insoluble; Ethanol: Insoluble; |
---|---|
DMSO(mg / mL) Max Solubility | 90 |
DMSO(mM) Max Solubility | 198.912611059541 |
Water(mg / mL) Max Solubility | <1 |
分子量 | 452.500 g/mol |
XLogP3 | 2.100 |
氢键供体数Hydrogen Bond Donor Count | 3 |
氢键受体数Hydrogen Bond Acceptor Count | 7 |
可旋转键计数Rotatable Bond Count | 8 |
精确质量Exact Mass | 452.17 Da |
单同位素质量Monoisotopic Mass | 452.17 Da |
拓扑极表面积Topological Polar Surface Area | 124.000 Ų |
重原子数Heavy Atom Count | 33 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 652.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Proton NMR spectrum | Conforms to structure |
---|---|
Purity(HPLC) | 98-100(%) |
Appearance(M413588) | White to Off-White to light yellow Solid |
1. Sintchak MD, Nimmesgern E. (2000) The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.. Immunopharmacology, 47 (2-3): (163-84). [PMID:10878288] [10.1021/op500134e] |
2. Kamiyama N, Soma R, Hidano S, Watanabe K, Umekita H, Fukuda C, Noguchi K, Gendo Y, Ozaki T, Sonoda A et al.. (2017) Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.. Antiviral Res, 146 (13): (1-11). [PMID:28818572] [10.1021/op500134e] |
3. Tong X, Smith J, Bukreyeva N, Koma T, Manning JT, Kalkeri R, Kwong AD, Paessler S. (2018) Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.. Antiviral Res, 149 (13): (34-40). [PMID:29126899] [10.1021/op500134e] |